| ABIVAX SA SP.ADR O.N. |
| USA |
| Gesundheit |
| US00370M1036 / A3EWCP |
| 2X10 (Frankfurt) / ABVX (NASDAQ) |
| FRA:2X10, ETR:2X10, 2X10:GR, NASDAQ:ABVX |
| - |
| https://www.abivax.com/ |
|
Abivax S.A. American Depositary Receipt represents shares in Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms, particularly through enhanced expression of micro..
>Volltext.. |
| 8084.02 Mio. EUR |
| 7577.04 Mio. EUR |
| - |
| -246.09 Mio. EUR |
| -333.19 Mio. EUR |
| -4.68 EUR |
| 32.65 Mio. EUR |
| 525.7 Mio. EUR |
| -159.08 Mio. EUR |
| 8.42 |
| - |
| -296.6% |
| - |
| - |
| - |
| - |
| ABIVAX ADR, ABIVAX |
| 05.04.26 |
|
||||
|